The Irish Times

Open Orphan subsidiary signs deal with global pharma company

Deal will see hVivo manufacture virus for use in human challenge studies

Wed May 04 2022 - 08:29

Venn Life Sciences wins another Covid-19 drug study

Open Orphan subsidiary to manage Phase 2 clinical trial for European pharma company

Mon Dec 07 2020 - 08:15

Open Orphan signs two year contract with German pharma company

Contract guarantees annual revenue for Dublin listed company

Fri Oct 30 2020 - 09:48

Open Orphan eyes profitability as it reports £4.1m ebitda loss

Company led by Cathal Friel recorded revenues of £7.1m for its first half

Wed Sept 30 2020 - 08:36

Open Orphan wins contract to support European pharma giant

Paris subsidiary Venn Life Sciences to work with oncology study enrolling 750 subjects

Tue Sept 22 2020 - 08:03

Open Orphan signs deal to carry out Covid-19 vaccine trial

Dublin listed company will carry out phase one trial at Hvivo facility

Tue Jul 28 2020 - 09:08

Open Orphan signs option to acquire company for ‘nominal sum’

The pharmaceutical company has three months to acquire CHIMagents

Wed Jul 15 2020 - 07:29

Open Orphan develops first challenge study model to test Covid-19 vaccines

Dublin-listed pharmaceutical services company publishes annual results for 2019

Wed Jun 24 2020 - 08:04

Open Orphan signs big deal with vaccine manufacturer

Agreement covers market access of newly developed medicine into EU and US markets

Thu Jun 11 2020 - 11:01

Open Orphan launches Covid-19 antibody testing service

London subsidiary Hvivo will carry out testing at its lab with 48-hour turnaround

Thu Jun 04 2020 - 07:47

Open Orphan raises €13.4m to ramp up Covid-19 study

Challenge study models could speed up the development of a vaccine by up to three years

Fri May 22 2020 - 07:34

Covid-19: Open Orphan to carry out 3,000 antibody tests per day

Antibody tests can detect if a person has had coronavirus before and has since recovered

Mon May 18 2020 - 07:39

Irish companies come out in force to help during Covid-19 pandemic

Issues with everything from drug trials to tech solutions, patient care are being tackled

Thu May 14 2020 - 03:03

Open Orphan to ‘boost revenue’ with new contract

Pharma services company to build on an existing relationship with German company

Mon Jan 06 2020 - 07:22

Open Orphan to merge with UK-based Hvivo in £30m tie-up

Deal values Hvivo at £12.96m, with its shareholders owning 44.7% of enlarged company

Mon Dec 09 2019 - 17:18

Irish skincare company Integumen raising €1.6m from share placing

Company to use funds to help boost revenues as it looks to double size of its laboratory

Mon Dec 09 2019 - 08:35

Open Orphan posts maiden loss as listed company

Pharma services business completed reverse takeover of Venn Life Sciences in June

Wed Sept 25 2019 - 11:52

Open Orphan resumes trading on markets following merger

Company chief executive Cathal Friel says it has ‘a clear growth strategy’ for shareholders

Fri Jun 28 2019 - 08:16

Venn Life Sciences to pursue ‘build to sell’ plan after merger

Combined group to fall under Open Orphan name

Tue Jun 11 2019 - 18:27

Cathal Friel reverses Open Orphan into listed Venn Life Sciences

Clinical trials group issues profit warning alongside results ahead of merger

Fri May 10 2019 - 11:37

Canadian pharma company appoints Dublin man to lead new Europe operation

Theratechnologies has appointed Conor Walshe to the role of general manager

Tue Feb 12 2019 - 11:54

Venn signs deal with Open Orphan to focus on rare diseases

Company has issued €1.1m in loan notes to fund specialisation in orphan diseases

Tue Dec 11 2018 - 07:43

Big Pharma bids to build bridges in Ireland

Irish industry’s chief looks for partnership as he admits trust is lacking

Sat Nov 03 2018 - 05:10

Venn shares hit new low as sales slide 15%

Clinical trials group falls to a loss but is optimistic for the future

Tue Sept 25 2018 - 18:58

European expansion on the cards for life sciences company

EY Entrepreneur of the Year finalist Tony Richardson, Venn Life Sciences

Mon Jul 09 2018 - 04:30

Venn Life Sciences raises £650,000 in share sale

Proceeds to be used for the acquisition by Venn Germany of CRM Biometrics

Wed Jul 04 2018 - 08:54

Losses for Venn Life Sciences as Integumen charges hit But

But earnings before interest, tax and exceptional items rose for the year

Thu May 17 2018 - 07:56

EY Entrepreneur of the Year: 24 companies shortlisted for award

Finalists employ more than 2,700 people and generate annual revenues of €150m

Mon Apr 23 2018 - 00:01

Venn Life Sciences reports rise in earnings despite fall in revenue

Irish drug development group targeting ‘higher value customer markets’

Thu Feb 15 2018 - 17:56

Revenue continues to rise at Venn Life Sciences

New financial year ‘started well’ with contract wins of €5.7m for clinical trials group

Thu Jul 20 2017 - 08:33

Dublin-based Venn Life Sciences records 57% rise in 2016 income

Firm says it secured €5.7 million worth of contract deals in first two months of 2017

Wed Mar 22 2017 - 12:20

No women directors, no problem, or so the view appears within Ireland Inc

Caveat: No gender quotas and no improvement in women director numbers

Fri Jan 06 2017 - 07:40

Venn Life Sciences wins €2.5m clinical trials contract

Company to carry out phase III study on behalf of Swedish firm Sedana Medical

Tue Nov 08 2016 - 07:49

Income more than doubles at clinical trials group Venn

Investment in synthetic skin project that is being sold widens operating loss

Wed Sept 28 2016 - 09:43